DocMorris AG (LON: 0RRB)

London flag London · Delayed Price · Currency is GBP · Price in CHF
20.04
-0.60 (-2.91%)
Jan 22, 2025, 5:32 PM BST
-72.69%
Market Cap 230.78M
Revenue (ttm) 883.01M
Net Income (ttm) -85.64M
Shares Out n/a
EPS (ttm) -7.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,186
Average Volume 8,581
Open 20.50
Previous Close 20.64
Day's Range 19.80 - 20.50
52-Week Range 19.80 - 101.25
Beta 1.40
RSI 42.17
Earnings Date Mar 13, 2025

About DocMorris AG

DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products. It also provides professional health care services. The company sells its products to online mail-order pharmacies, and private individuals under the PromoFarma by DocMorris, TeleClinic, and DocMorris brands. The compa... [Read more]

Sector Healthcare
Founded 1993
Employees 1,453
Stock Exchange London Stock Exchange
Ticker Symbol 0RRB
Full Company Profile

Financial Performance

Financial numbers in CHF Financial Statements

News

DocMorris AG (ZRSEF) Q2 2024 Earnings Call Transcript

DocMorris AG (OTCPK:ZRSEF) Q2 2024 Earnings Call Transcript August 20, 2024 5:00 AM ET Company Participants Walter Hess - CEO Marcel Ziwica - CFO Conference Call Participants Urs Kunz - Research Partn...

5 months ago - Seeking Alpha

DocMorris AG (ZRSEF) Q4 2023 Earnings Call Transcript

DocMorris AG (ZRSEF) Q4 2023 Earnings Call Transcript

10 months ago - Seeking Alpha

Online drug retailer DocMorris meets expectations as cost savings help

Swiss online drug retailer DocMorris met expectations on Thursday as it released its full-year results for 2023, helped by structural cost savings.

11 months ago - Reuters

Online drug retailer DocMorris trims top end of 2023 outlook

Swiss online drug retailer DocMorris on Thursday narrowed down the higher end of its annual core loss forecast, citing weaker development in the paper prescription business.

1 year ago - Reuters

DocMorris AG (ZRSEF) Q2 2023 Earnings Call Transcript

DocMorris AG (OTCPK:ZRSEF) Q2 2023 Earnings Conference Call August 17, 2023 5:00 AM ET Company Participants Walter Hess - CEO Madhu Nutakki - Chief Technology Officer Marcel Ziwica - CFO Conference Ca...

1 year ago - Seeking Alpha